Skip to main content
Livermore
Livermore
ZHEN

Walleye Capital LLC

SEC CIK
0001758720
Latest filing
Aug 3, 2026

SRPT holding history

Sarepta Therapeutics, Inc. in every 13F filed by Walleye Capital LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SRPT overviewAll 13F holders of SRPTFull Q2 2026 holdings

Shares (Q2 2026)
34,421
Value
$618.5K
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of SRPT by Walleye Capital LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202634,421$618.5K<0.1%−254,111−88.1%ReducedHolders
Q1 2026288,532$6.28M<0.1%+15,800+5.8%AddedHolders
Q4 2025272,732$5.87M<0.1%+115,952+74.0%AddedHolders
Q3 2025156,780$3.02M<0.1%−279,445−64.1%ReducedHolders
Q2 2025436,225$7.46M0.1%+423,278+3,269.3%AddedHolders
Q1 202512,947$826.3K<0.1%+8,515+192.1%AddedHolders
Q4 20244,432$538.9K<0.1%−5,453−55.2%ReducedHolders
Q3 20249,885$1.23M<0.1%−25,777−72.3%ReducedHolders
Q2 202435,662$5.63M0.1%−4,317−10.8%ReducedHolders
Q1 202439,979$5.18M0.1%−68,862−63.3%ReducedHolders
Q4 2023108,841$10.5M0.1%+67,073+160.6%AddedHolders
Q3 202341,768$5.06M0.1%+31,032+289.0%AddedHolders
Q2 202310,736$1.23M<0.1%−9,593−47.2%ReducedHolders
Q1 202320,329$2.80M0.1%−27,340−57.4%ReducedHolders
Q4 202247,669$6.18M0.1%+47,669NewHolders
Q2 20220$00.0%−53,361−100.0%Sold outHolders
Q1 202253,361$4.17M0.1%+31,488+144.0%AddedHolders
Q4 202121,873$1.97M0.1%+17,626+415.0%AddedHolders
Q3 20214,247$393.0K<0.1%+4,247NewHolders
Q2 20210$00.0%−11,282−100.0%Sold outHolders
Q1 202111,282$841.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.